1. Home
  2. OBAI vs CMMB Comparison

OBAI vs CMMB Comparison

Compare OBAI & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.36

Market Cap

15.2M

ML Signal

N/A

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

N/A

Current Price

$1.92

Market Cap

13.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OBAI
CMMB
Founded
2017
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
13.8M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
OBAI
CMMB
Price
$0.36
$1.92
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
629.2K
61.8K
Earning Date
05-27-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
40.53
101.67
EPS
N/A
0.04
Revenue
$9,972,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$47.75
Revenue Growth
2.42
N/A
52 Week Low
$0.36
$0.88
52 Week High
$19.95
$3.86

Technical Indicators

Market Signals
Indicator
OBAI
CMMB
Relative Strength Index (RSI) 34.24 62.20
Support Level N/A $1.41
Resistance Level $0.65 $2.21
Average True Range (ATR) 0.05 0.12
MACD -0.00 0.04
Stochastic Oscillator 10.83 81.10

Price Performance

Historical Comparison
OBAI
CMMB

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: